Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
WALTERS GROUP reported a 18.80% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G/A)
Event Aug 14, 2026 · Filed Aug 19, 2026
WALTERS GROUP reported a 18.80% stake in Zentalis Pharmaceuticals, Inc., 17,844,973 shares, as a passive investor on Aug 14, 2026. Filed Aug 19, 2026 (Schedule 13G/A).
- Stake
- 18.80%
- Shares
- 17,844,973
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Walters William T | 18.80% | 17,844,973 |
| WALTERS GROUP | 18.80% | 17,844,973 |
| Walters, Susan B. | 18.80% | 17,844,973 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Walters Group
- Zentalis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Walters Group · Jan 5, 2026
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Johnson David Michael · Jun 18, 2026